Download PDF
J Neurol Surg B Skull Base 2012; 73(04): 245-252
DOI: 10.1055/s-0032-1312716
Original Article

Safety Profile of Bone Marrow Mononuclear Stem Cells in the Rehabilitation of Patients with Posttraumatic Facial Nerve Paralysis—A Novel Modality (Phase One Trial)

Sushil Kumar Aggarwal
1   Department of Neuro-Otology, SGPGIMS, Lucknow, Uttar Pradesh, India
,
Ashok Kumar Gupta
2   Department of Otolaryngology, PGIMER, Chandigarh, The Union Territory, India
,
Manish Modi
3   Department of Neurology, PGIMER, Chandigarh, The Union Territory, India
,
Rijuneeta Gupta
2   Department of Otolaryngology, PGIMER, Chandigarh, The Union Territory, India
,
Neelam Marwaha
4   Department of Transfusion Medicine, PGIMER, Chandigarh, The Union Territory, India
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Objectives The objectives of this study were to study the safety profile and role of mononuclear stem cells in the rehabilitation of posttraumatic facial nerve paralysis not improving with conventional treatment.

Study Design This is a prospective nonrandomized controlled trial.

Study Setting This study is conducted at Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh between July, 2007 and December, 2008.

Patients We included eight patients of either sex aged between 18 and 60 years of posttraumatic facial nerve paralysis not improving with conventional treatment presented to PGIMER, Chandigarh between July 2007 and December 2008.

Methods All patients underwent preoperative electroneuronography (ENoG), clinical photography, and high-resolution computed tomography (HRCT) temporal bone. All patients then underwent facial nerve decompression and stem cell implantation. Stem cells processing was done in well-equipped bone marrow laboratory. Postoperatively, all patients underwent repeat ENoG and clinical photography at 3 and 6 months to assess for objective and clinical improvement. Clinical improvement was graded according to modified House–Brackmann grading system.

Intervention Done All patients of posttraumatic facial nerve paralysis who were not improving with conventional surgical treatment were subjected to facial nerve decompression and stem cell implantation.

Main Outcome Measures All patients who were subjected to stem cell implantation were followed up for 6 months to assess for any adverse effects of stem cell therapy on human beings; no adverse effects were seen in any of our patients after more than 6 months of follow-up.

Results Majority of the patients were male, with motor vehicle accidents as the most common cause of injury in our series. Majority had longitudinal fractures on HRCT temporal bone. The significant improvement in ENoG amplitude was seen between preoperative and postoperative amplitudes on involved side which was statistically significant (0.041). Clinical improvement seen was statistically significant both for eye closure (p < 0.010) and for deviation of angle of mouth (p < 0.008) at 6-month follow-up in 85% of our patients, far better than the results of previous conventional surgeries.

Conclusion Stem cell therapy can be used safely in human beings without any adverse effects on humans, and it appears to be a promising modality for rehabilitation of patients with posttraumatic facial nerve paralysis not improving with conventional surgical treatment but few more clinical series are required for validation.

Keywords

traumatic facial nerve paralysis - stem cell therapy - rehabilitation


Publication History

Received: 05 October 2011

Accepted: 07 December 2011

Publication Date:
17 May 2012 (online)

© 2012. Thieme. All rights reserved.

Thieme Medical Publishers
333 Seventh Avenue, New York, NY 10001, USA.

 

  • References

  • 1 Crosby EC, Dejonge BR. Experimental and clinical studies of the central connections and central relations of the facial nerve. Ann Otol Rhinol Laryngol 1963; 72: 735-755
    CrossrefPubMedGoogle Scholar
  • 2 Carpenter MB. Human Neuroanatomy. 7th ed. Baltimore: Williams and Wilkins; 1976
    Google Scholar
  • 3 May M, Klein SR. Differential diagnosis of facial nerve palsy. Otolaryngol Clin North Am 1991; 24 (03) 613-645
    CrossrefPubMedGoogle Scholar
  • 4 Ellis JC, McCaffrey TV. Nerve grafting. Functional results after primary vs delayed repair. Arch Otolaryngol 1985; 111 (12) 781-785
    CrossrefPubMedGoogle Scholar
  • 5 Griffin JE, Altenau MM, Schaefer SD. Bilateral longitudinal temporal bone fractures: a retrospective review of seventeen cases. Laryngoscope 1979; 89 (09) 1432-1435
    CrossrefPubMedGoogle Scholar
  • 6 Kamerer DB. Intratemporal facial nerve injuries. Otolaryngol Head Neck Surg 1982; 90 (05) 612-615
    CrossrefPubMedGoogle Scholar
  • 7 McKennan KX, Chole RA. Facial paralysis in temporal bone trauma. Am J Otol 1992; 13 (02) 167-172
    PubMedGoogle Scholar
  • 8 Green Jr JD, Shelton C, Brackmann DE. Surgical management of iatrogenic facial nerve injuries. Otolaryngol Head Neck Surg 1994; 111 (05) 606-610
    CrossrefPubMedGoogle Scholar
  • 9 House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg 1985; 93 (02) 146-147
    CrossrefPubMedGoogle Scholar
  • 10 Esslen E. Investigation on the localization and pathogensis of meatolabyrinthine palsies. In: Esslen E. ed. Acute Facial Palsies. New York: Springer-Verlag; 1977
    Google Scholar
  • 11 Fisch U. Surgery for Bell's palsy. Arch Otolaryngol 1981; 107 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 12 Beck DL, Hall III JW. Evaluation of the facial nerve via electroneuronography (ENoG). The Hearing J 2001; 54 (03) 36-44
    CrossrefPubMedGoogle Scholar
  • 13 Fisch U. Prognostic value of electrical tests in acute facial paralysis. Am J Otol 1984; 5 (06) 494-498
    PubMedGoogle Scholar
  • 14 Nageris B, Hansen MC, Lavelle WG, Van Pelt FA. Temporal bone fractures. Am J Emerg Med 1995; 13 (02) 211-214
    CrossrefPubMedGoogle Scholar
  • 15 Virapongse C, Bhimani S, Sarwar M. Radiography of the abnormal ear. In: Taveras JM, Ferrucii JT. eds. Radiology: Diagnosis-Imaging-Intervention, 3. Philadelphia: 1987
    Google Scholar
  • 16 Brodie HA, Thompson TC. Management of complications from 820 temporal bone fractures. Am J Otol 1997; 18 (02) 188-197
    PubMedGoogle Scholar
  • 17 Cannon CR, Jahrsdoerfer RA. Temporal bone fractures. Review of 90 cases. Arch Otolaryngol 1983; 109 (05) 285-288
    CrossrefPubMedGoogle Scholar
  • 18 Wiet RJ, Valvassori GE, Kotsanis CA, Parahy C. Temporal bone fractures. State of the art review. Am J Otol 1985; 6 (03) 207-215
    PubMedGoogle Scholar
  • 19 Quaranta A, Campobasso G, Piazza F, Quaranta N, Salonna I. Facial nerve paralysis in temporal bone fractures: outcomes after late decompression surgery. Acta Otolaryngol 2001; 121 (05) 652-655
    CrossrefPubMedGoogle Scholar
  • 20 May M, Sobol SM, Mester SJ. Managing segmental facial nerve injuries by surgical repair. Laryngoscope 1990; 100 (10) 1062-1067
    CrossrefPubMedGoogle Scholar
  • 21 Haïk S, Gauthier LR, Granotier C. , et al. Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells. Oncogene 2000; 19 (26) 2957-2966
    CrossrefPubMedGoogle Scholar
  • 22 Naito Y, Nakamura T, Nakagawa T. , et al. Transplantation of bone marrow stromal cells into the cochlea of chinchillas. Neuroreport 2004; 15 (01) 1-4
    CrossrefPubMedGoogle Scholar
  • 23 Svendsen CN, Langston JW. Stem cells for Parkinson disease and ALS: replacement or protection?. Nat Med 2004; 10 (03) 224-225
    CrossrefPubMedGoogle Scholar
  • 24 Glarner H, Meuli M, Hof E. , et al. Management of petrous bone fractures in children: analysis of 127 cases. J Trauma 1994; 36 (02) 198-201
    CrossrefPubMedGoogle Scholar
  • 25 Matsuoka AJ, Kondo T, Miyamoto RT, Hashino E. In vivo and in vitro characterization of bone marrow-derived stem cells in the cochlea. Laryngoscope 2006; 116 (08) 1363-1367
    CrossrefPubMedGoogle Scholar